ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

ClinicalTrials.gov ID: NCT01339091

Public ClinicalTrials.gov record NCT01339091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regiment (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Study identification

NCT ID
NCT01339091
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Durata Therapeutics Inc., an affiliate of Allergan plc
Industry
Enrollment
573 participants

Conditions and interventions

Interventions

  • Dalbavancin Drug
  • Vancomycin / Linezolid Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Aug 31, 2012
Completion
Oct 31, 2012
Last update posted
Jan 30, 2014

2011 – 2012

United States locations

U.S. sites
55
U.S. states
16
U.S. cities
53
Facility City State ZIP Site status
Durata Study Site Anaheim California 92804
Durata Study Site Azusa California 91702
Durata Study Site Bellflower California 90706
Durata Study Site Buena Park California 90620
Durata Study Site Carmel California 46032
Durata Study Site Chula Vista California 92911
Durata Study Site Covina California 91723
Durata Study Site Fountain Valley California 92708
Durata Study Site La Mesa California 91942
Durata Study Site Long Beach California 90813
Durata Study Site Los Alamitos California 90720
Durata Study Site Los Angeles California 90015
Durata Study Site Oceanside California 92056
Durata Study Site Palm Desert California 92211
Durata Study Site Pasadena California 91105
Durata Study Site Sacramento California 95817
Durata Study Site San Diego California 92120
Durata Study Site Santa Ana California 92701
Durata Study Site Sylmar California 91342
Durata Study Site Torrance California 90509
Durata Study Site Upland California 91786
Durata Study Site Whittier California 90602
Durata Study Site Miami Florida 33144
Durata Study Site Miami Florida 33155
Durata Study Site Orlando Florida 32837
Durata Study Site Saint Cloud Florida 34769
Durata Study Site Tampa Florida 33613
Durata Study Site Columbus Georgia 31904
Durata Study Site Savannah Georgia 31406
Durata Study Site Idaho Falls Idaho 83404
Durata Study Site Pocatello Idaho 83202
Durata Study Site Moline Illinois 61265
Durata Study Site Rock Island Illinois 31201
Durata Study Site Baton Rouge Louisiana 70808
Durata Study Site Lafayette Louisiana 70503
Durata Clinical Site New Orleans Louisiana 70112
Durata Study Site Opelousas Louisiana 70570
Durata Study Site Detroit Michigan 48202
Durata Study Site Minneapolis Minnesota 55422
Durata Study Site Las Vegas Nevada 89109
Durata Study Site Somers Point New Jersey 08244
Durata Study Site Buffalo New York 14215
Durata Study Site Lake Success New York 11042
Durata Study Site New Hyde Park New York 11040
Durata Study Site Staten Island New York 10305
Durata Study Site The Bronx New York 10467
Durata Study Site Winston-Salem North Carolina 27103
Durata Study Site Columbus Ohio 43215
Durata Study Site Lima Ohio 45801
Durata Study Site Toledo Ohio 43608
Durata Study Site Pittsburgh Pennsylvania 15213
Durata Study Site Houston Texas 77030
Durata Study Site Houston Texas 77036
Durata Study Site Madison Wisconsin 53717
Durata Study Site Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01339091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2014 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01339091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →